NPASS Compound

Structure

CID194499 OpenBabel06191715582D 31 34 0 0 1 0 0 0 0 0999 V2000 -2.5981 -2.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8660 3.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 -3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.3660 -0.3660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.8660 0.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7321 1.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 2.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.4152 -1.3090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8660 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.0029 -0.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5981 0.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5981 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7321 3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8660 -2.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.4641 -1.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7321 -0.0000 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -3.4641 -0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8660 1.5000 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -1.7321 -1.0000 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.8660 -1.5000 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 0.0000 -1.0000 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.8660 0.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8660 0.5000 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 0.0000 -0.0000 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -2.5981 3.5000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.7321 -3.0000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.8660 -2.5000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.8660 -0.5000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.4152 0.3090 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.7321 2.0000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.8660 -1.5000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 12 2 0 0 0 0 2 13 1 0 0 0 0 3 14 1 0 0 0 0 4 22 1 0 0 0 0 5 22 1 0 0 0 0 6 23 1 0 0 0 0 7 9 1 0 0 0 0 7 18 1 0 0 0 0 8 10 2 0 0 0 0 8 15 1 0 0 0 0 9 22 1 0 0 0 0 10 29 1 0 0 0 0 11 16 1 0 0 0 0 11 17 1 0 0 0 0 12 15 1 0 0 0 0 13 25 2 0 0 0 0 13 30 1 0 0 0 0 14 26 2 0 0 0 0 14 31 1 0 0 0 0 15 17 2 0 0 0 0 16 19 1 0 0 0 0 16 23 1 6 0 0 0 17 29 1 0 0 0 0 18 23 1 1 0 0 0 18 30 1 0 0 0 0 19 12 1 1 0 0 0 19 20 1 0 0 0 0 20 21 1 0 0 0 0 20 27 1 6 0 0 0 21 24 1 1 0 0 0 21 31 1 0 0 0 0 22 24 1 0 0 0 0 23 24 1 6 0 0 0 24 28 1 1 0 0 0 M END $$$$

Physi-Chem Properties

Molecular Weight:	432.21
Volume:	437.784
LogP:	2.816
LogD:	2.289
LogS:	-4.03
# Rotatable Bonds:	4
TPSA:	106.2
# H-Bond Aceptor:	7
# H-Bond Donor:	2
# Rings:	4
# Heavy Atoms:	7

MedChem Properties

QED Drug-Likeness Score:	0.692
Synthetic Accessibility Score:	5.044
Fsp3:	0.667
Lipinski Rule-of-5:	Accepted
Pfizer Rule:	Accepted
GSK Rule:	Rejected
BMS Rule:	0
Golden Triangle Rule:	Accepted
Chelating Alert:	0
PAINS Alert:	0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:	-4.891
MDCK Permeability:	2.002013206947595e-05
Pgp-inhibitor:	0.913
Pgp-substrate:	0.006
Human Intestinal Absorption (HIA):	0.07
20% Bioavailability (F20%):	0.011
30% Bioavailability (F30%):	0.378

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):	0.299
Plasma Protein Binding (PPB):	78.61161041259766%
Volume Distribution (VD):	2.185
Pgp-substrate:	26.535123825073242%

ADMET: Metabolism

CYP1A2-inhibitor:	0.057
CYP1A2-substrate:	0.052
CYP2C19-inhibitor:	0.025
CYP2C19-substrate:	0.397
CYP2C9-inhibitor:	0.147
CYP2C9-substrate:	0.081
CYP2D6-inhibitor:	0.022
CYP2D6-substrate:	0.161
CYP3A4-inhibitor:	0.508
CYP3A4-substrate:	0.274

ADMET: Excretion

Clearance (CL):	3.323
Half-life (T1/2):	0.245

ADMET: Toxicity

hERG Blockers:	0.82
Human Hepatotoxicity (H-HT):	0.501
Drug-inuced Liver Injury (DILI):	0.847
AMES Toxicity:	0.066
Rat Oral Acute Toxicity:	0.808
Maximum Recommended Daily Dose:	0.316
Skin Sensitization:	0.296
Carcinogencity:	0.489
Eye Corrosion:	0.006
Eye Irritation:	0.012
Respiratory Toxicity:	0.971

Download Data

Data Type	Select
General Info & Identifiers & Properties
Structure MOL file
Source Organisms
Biological Activities
Similar NPs/Drugs

Natural Product: NPC194499

Natural Product ID:	NPC194499
*Common Name:**	Bonducellpin G
IUPAC Name:	[(1S,4aR,5S,6R,6aR,11aS,11bS)-5-acetyloxy-4a,6-dihydroxy-4,4,11b-trimethyl-7-methylidene-1,2,3,5,6,6a,11,11a-octahydronaphtho[2,1-f][1]benzofuran-1-yl] acetate
Synonyms:	Bonducellpin G
Standard InCHIKey:	IHXOABPCUNFFPZ-FRZBIBBKSA-N
Standard InCHI:	InChI=1S/C24H32O7/c1-12-15-8-10-29-17(15)11-16-19(12)20(27)21(31-14(3)26)24(28)22(4,5)9-7-18(23(16,24)6)30-13(2)25/h8,10,16,18-21,27-28H,1,7,9,11H2,2-6H3/t16-,18-,19-,20+,21-,23-,24+/m0/s1
SMILES:	C=C1c2ccoc2C[C@H]2[C@H]1[C@H]([C@@H]([C@]1(C(C)(C)CC[C@@H]([C@]21C)OC(=O)C)O)OC(=O)C)O
Synthetic Gene Cluster:	n.a.
ChEMBL Identifier:	CHEMBL400084
PubChem CID:	23643018
Chemical Classification:**	CHEMONTID:0000000 [Organic compounds] [CHEMONTID:0000012] Lipids and lipid-like molecules [CHEMONTID:0000259] Prenol lipids [CHEMONTID:0001551] Diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

Species Source

Organism ID	Organism Name	Taxonomy Level	Family	SuperKingdom	Isolation Part	Collection Location	Collection Time	Reference
NPO29844	Caesalpinia bonduc	Species	Fabaceae	Eukaryota	n.a.	bark	n.a.	PMID[17329887]
NPO29844	Caesalpinia bonduc	Species	Fabaceae	Eukaryota	seed kernels	Amphur Sanamchaikate, Chachoengsao Province, Thailand	2005-JUN	PMID[17848088]
NPO11853	Eucalyptus froggattii	Species	Myrtaceae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]
NPO7886	Eria tomentosa	Species	Orchidaceae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]
NPO13248	Pistacia mexicana	Species	Anacardiaceae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

NP Quantity Composition/Concentration

Organism ID	NP ID	Organism Material Preparation	Organism Part	NP Quantity (Standard)	NP Quantity (Minimum)	NP Quantity (Maximum)	Quantity Unit	Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

Biological Activity

Activity Type	# Activity
IC50	1

Activity Type	# Activity
Organism	1

Target ID	Target Type	Target Name	Target Organism	Activity Type	Activity Relation	Value	Unit	Reference
NPT6	Organism	Plasmodium falciparum	Plasmodium falciparum	IC50	=	3800.0	nM	PMID[484297]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

● The left chart: Distribution of similarity level between NPC194499 and all remaining natural products in the NPASS database.
● The right table: Most similar natural products (Tc>=0.56 or Top200).

range	Tanimoto Coefficient
0-0.1	324
0.1-0.2	1211
0.2-0.3	2623
0.3-0.4	4824
0.4-0.5	9513
0.5-0.6	8954
0.6-0.7	7033
0.7-0.8	7479
0.8-0.85	494
0.85-0.9	180
0.9-0.95	41
0.95-1	21

Similarity Score	Similarity Level	Natural Product ID
0.9866	High Similarity	NPC88007
0.9733	High Similarity	NPC195954
0.973	High Similarity	NPC294511
0.973	High Similarity	NPC121615
0.9671	High Similarity	NPC68848
0.9671	High Similarity	NPC79571
0.9608	High Similarity	NPC283209
0.9605	High Similarity	NPC8389
0.9595	High Similarity	NPC228842
0.9595	High Similarity	NPC212257
0.9542	High Similarity	NPC18986
0.9542	High Similarity	NPC188649
0.9484	High Similarity	NPC121995
0.9481	High Similarity	NPC285567
0.9481	High Similarity	NPC288602
0.9481	High Similarity	NPC88841
0.9474	High Similarity	NPC7059
0.9408	High Similarity	NPC41880
0.9396	High Similarity	NPC125182
0.9396	High Similarity	NPC69647
0.9392	High Similarity	NPC71821
0.9363	High Similarity	NPC296558
0.9359	High Similarity	NPC277618
0.9351	High Similarity	NPC287559
0.9346	High Similarity	NPC304692
0.9286	High Similarity	NPC474611
0.9281	High Similarity	NPC104736
0.9262	High Similarity	NPC255414
0.9177	High Similarity	NPC270312
0.9172	High Similarity	NPC56358
0.9128	High Similarity	NPC5676
0.9119	High Similarity	NPC255787
0.9062	High Similarity	NPC118086
0.9057	High Similarity	NPC310572
0.9054	High Similarity	NPC263337
0.9038	High Similarity	NPC140952
0.9026	High Similarity	NPC34421
0.9026	High Similarity	NPC98206
0.9026	High Similarity	NPC253201
0.9026	High Similarity	NPC237259
0.9026	High Similarity	NPC302054
0.9013	High Similarity	NPC211625
0.9006	High Similarity	NPC475641
0.9006	High Similarity	NPC475237
0.9	High Similarity	NPC291742
0.8994	High Similarity	NPC308156
0.8987	High Similarity	NPC472773
0.8987	High Similarity	NPC476035
0.8987	High Similarity	NPC475039
0.8987	High Similarity	NPC14499
0.8974	High Similarity	NPC81405
0.8961	High Similarity	NPC472672
0.8961	High Similarity	NPC268905
0.8926	High Similarity	NPC121158
0.8924	High Similarity	NPC470792
0.8924	High Similarity	NPC200782
0.8924	High Similarity	NPC472771
0.8917	High Similarity	NPC84349
0.8917	High Similarity	NPC475967
0.8903	High Similarity	NPC114880
0.8889	High Similarity	NPC294512
0.8882	High Similarity	NPC216755
0.8875	High Similarity	NPC475779
0.8854	High Similarity	NPC299038
0.8854	High Similarity	NPC472776
0.8854	High Similarity	NPC472778
0.8854	High Similarity	NPC472777
0.8851	High Similarity	NPC202260
0.8848	High Similarity	NPC11062
0.8846	High Similarity	NPC141538
0.8846	High Similarity	NPC155939
0.8846	High Similarity	NPC92979
0.8846	High Similarity	NPC296807
0.8839	High Similarity	NPC33938
0.8831	High Similarity	NPC470997
0.8827	High Similarity	NPC470995
0.882	High Similarity	NPC472774
0.882	High Similarity	NPC41689
0.882	High Similarity	NPC472775
0.8812	High Similarity	NPC62692
0.8812	High Similarity	NPC61967
0.8812	High Similarity	NPC27541
0.8812	High Similarity	NPC126984
0.8812	High Similarity	NPC276551
0.8805	High Similarity	NPC82851
0.8797	High Similarity	NPC472671
0.8797	High Similarity	NPC123153
0.8792	High Similarity	NPC67003
0.8766	High Similarity	NPC234494
0.8765	High Similarity	NPC271235
0.8765	High Similarity	NPC160651
0.8765	High Similarity	NPC471397
0.8758	High Similarity	NPC470875
0.8758	High Similarity	NPC471174
0.8758	High Similarity	NPC286038
0.8758	High Similarity	NPC86800
0.875	High Similarity	NPC302369
0.875	High Similarity	NPC477405
0.875	High Similarity	NPC39986
0.875	High Similarity	NPC292389
0.875	High Similarity	NPC134254
0.875	High Similarity	NPC469338
0.8742	High Similarity	NPC243577
0.8742	High Similarity	NPC472299
0.8742	High Similarity	NPC335761
0.8734	High Similarity	NPC472772
0.8734	High Similarity	NPC475066
0.8734	High Similarity	NPC214495
0.8734	High Similarity	NPC470119
0.8727	High Similarity	NPC176413
0.8727	High Similarity	NPC56953
0.8726	High Similarity	NPC75310
0.8726	High Similarity	NPC264943
0.8718	High Similarity	NPC476201
0.8718	High Similarity	NPC246164
0.8718	High Similarity	NPC469503
0.8716	High Similarity	NPC307401
0.8712	High Similarity	NPC88593
0.8704	High Similarity	NPC173516
0.8704	High Similarity	NPC472282
0.8701	High Similarity	NPC66991
0.8701	High Similarity	NPC19747
0.8701	High Similarity	NPC471007
0.8696	High Similarity	NPC276735
0.8696	High Similarity	NPC470182
0.8696	High Similarity	NPC470940
0.8696	High Similarity	NPC469849
0.8693	High Similarity	NPC62799
0.8688	High Similarity	NPC69028
0.8688	High Similarity	NPC471003
0.8688	High Similarity	NPC5079
0.8688	High Similarity	NPC329938
0.8688	High Similarity	NPC263432
0.8684	High Similarity	NPC251865
0.8679	High Similarity	NPC475226
0.8679	High Similarity	NPC307383
0.8675	High Similarity	NPC472665
0.8662	High Similarity	NPC282445
0.8662	High Similarity	NPC178932
0.8645	High Similarity	NPC472654
0.8645	High Similarity	NPC470998
0.8642	High Similarity	NPC472141
0.8642	High Similarity	NPC93172
0.8642	High Similarity	NPC97574
0.8634	High Similarity	NPC51568
0.8634	High Similarity	NPC234660
0.8625	High Similarity	NPC470789
0.8625	High Similarity	NPC472653
0.8625	High Similarity	NPC477402
0.8616	High Similarity	NPC197137
0.8616	High Similarity	NPC470118
0.8616	High Similarity	NPC261597
0.8616	High Similarity	NPC249021
0.8616	High Similarity	NPC45101
0.8616	High Similarity	NPC167142
0.8608	High Similarity	NPC476262
0.8608	High Similarity	NPC214541
0.8608	High Similarity	NPC44675
0.8608	High Similarity	NPC35000
0.8608	High Similarity	NPC469336
0.86	High Similarity	NPC100913
0.86	High Similarity	NPC275592
0.8599	High Similarity	NPC48671
0.8599	High Similarity	NPC475777
0.8598	High Similarity	NPC302392
0.859	High Similarity	NPC196846
0.8589	High Similarity	NPC473753
0.8589	High Similarity	NPC472651
0.8589	High Similarity	NPC473766
0.8581	High Similarity	NPC476947
0.858	High Similarity	NPC476857
0.858	High Similarity	NPC261184
0.858	High Similarity	NPC476856
0.858	High Similarity	NPC271657
0.858	High Similarity	NPC476858
0.8571	High Similarity	NPC207978
0.8571	High Similarity	NPC18347
0.8571	High Similarity	NPC149896
0.8562	High Similarity	NPC472823
0.8553	High Similarity	NPC107646
0.8544	High Similarity	NPC30222
0.8543	High Similarity	NPC291599
0.8543	High Similarity	NPC118080
0.8543	High Similarity	NPC87448
0.8543	High Similarity	NPC97947
0.8543	High Similarity	NPC148374
0.8543	High Similarity	NPC27377
0.8543	High Similarity	NPC41481
0.8543	High Similarity	NPC472576
0.8537	High Similarity	NPC472652
0.8535	High Similarity	NPC18135
0.8528	High Similarity	NPC307781
0.8528	High Similarity	NPC472670
0.8526	High Similarity	NPC471001
0.8526	High Similarity	NPC195325
0.8519	High Similarity	NPC476197
0.8519	High Similarity	NPC472139
0.8509	High Similarity	NPC25255
0.8506	High Similarity	NPC41182
0.85	High Similarity	NPC1408

Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

● The left chart: Distribution of similarity level between NPC194499 and all drugs/candidates.
● The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

range	Tanimoto Coefficient
0-0.1	284
0.1-0.2	801
0.2-0.3	1600
0.3-0.4	2527
0.4-0.5	2143
0.5-0.6	1198
0.6-0.7	459
0.7-0.8	129
0.8-0.85	9
0.85-0.9	0
0.9-0.95	0
0.95-1	0

Similarity Score	Similarity Level	Drug ID	Developmental Stage
0.8802	High Similarity	NPD8434	Phase 2
0.8375	Intermediate Similarity	NPD5761	Phase 2
0.8375	Intermediate Similarity	NPD5760	Phase 2
0.8312	Intermediate Similarity	NPD4628	Phase 3
0.8284	Intermediate Similarity	NPD6765	Approved
0.8284	Intermediate Similarity	NPD6764	Approved
0.8092	Intermediate Similarity	NPD6785	Approved
0.8092	Intermediate Similarity	NPD6784	Approved
0.7927	Intermediate Similarity	NPD7096	Clinical (unspecified phase)
0.7895	Intermediate Similarity	NPD5844	Phase 1
0.7861	Intermediate Similarity	NPD6559	Discontinued
0.7857	Intermediate Similarity	NPD8127	Discontinued
0.7853	Intermediate Similarity	NPD6599	Discontinued
0.7844	Intermediate Similarity	NPD5537	Clinical (unspecified phase)
0.7826	Intermediate Similarity	NPD6273	Approved
0.7818	Intermediate Similarity	NPD7819	Suspended
0.7785	Intermediate Similarity	NPD7421	Clinical (unspecified phase)
0.7784	Intermediate Similarity	NPD7075	Discontinued
0.7784	Intermediate Similarity	NPD8055	Clinical (unspecified phase)
0.7771	Intermediate Similarity	NPD2343	Clinical (unspecified phase)
0.7764	Intermediate Similarity	NPD7004	Clinical (unspecified phase)
0.7725	Intermediate Similarity	NPD4868	Clinical (unspecified phase)
0.7683	Intermediate Similarity	NPD7458	Discontinued
0.7651	Intermediate Similarity	NPD6801	Discontinued
0.764	Intermediate Similarity	NPD7236	Approved
0.7625	Intermediate Similarity	NPD6398	Clinical (unspecified phase)
0.7617	Intermediate Similarity	NPD8404	Phase 2
0.7605	Intermediate Similarity	NPD2393	Clinical (unspecified phase)
0.7593	Intermediate Similarity	NPD6799	Approved
0.7588	Intermediate Similarity	NPD5494	Approved
0.7574	Intermediate Similarity	NPD3749	Approved
0.7572	Intermediate Similarity	NPD7473	Discontinued
0.7561	Intermediate Similarity	NPD920	Approved
0.756	Intermediate Similarity	NPD3817	Phase 2
0.7545	Intermediate Similarity	NPD37	Approved
0.7545	Intermediate Similarity	NPD1934	Approved
0.7544	Intermediate Similarity	NPD7199	Phase 2
0.753	Intermediate Similarity	NPD4380	Phase 2
0.7529	Intermediate Similarity	NPD919	Approved
0.7529	Intermediate Similarity	NPD3818	Discontinued
0.7515	Intermediate Similarity	NPD4967	Phase 2
0.7515	Intermediate Similarity	NPD4966	Approved
0.7515	Intermediate Similarity	NPD4965	Approved
0.7485	Intermediate Similarity	NPD7411	Suspended
0.7484	Intermediate Similarity	NPD6100	Approved
0.7484	Intermediate Similarity	NPD6099	Approved
0.7473	Intermediate Similarity	NPD7879	Clinical (unspecified phase)
0.7472	Intermediate Similarity	NPD8312	Approved
0.7472	Intermediate Similarity	NPD8313	Approved
0.7471	Intermediate Similarity	NPD4381	Clinical (unspecified phase)
0.747	Intermediate Similarity	NPD3226	Approved
0.747	Intermediate Similarity	NPD5808	Clinical (unspecified phase)
0.7456	Intermediate Similarity	NPD8443	Clinical (unspecified phase)
0.7455	Intermediate Similarity	NPD6980	Clinical (unspecified phase)
0.7452	Intermediate Similarity	NPD6355	Discontinued
0.7439	Intermediate Similarity	NPD642	Clinical (unspecified phase)
0.7427	Intermediate Similarity	NPD6234	Discontinued
0.7423	Intermediate Similarity	NPD643	Clinical (unspecified phase)
0.7414	Intermediate Similarity	NPD6166	Phase 2
0.7414	Intermediate Similarity	NPD6167	Clinical (unspecified phase)
0.7414	Intermediate Similarity	NPD6168	Clinical (unspecified phase)
0.7412	Intermediate Similarity	NPD3882	Suspended
0.741	Intermediate Similarity	NPD7239	Suspended
0.7407	Intermediate Similarity	NPD3750	Approved
0.7401	Intermediate Similarity	NPD7993	Clinical (unspecified phase)
0.7399	Intermediate Similarity	NPD6232	Discontinued
0.7378	Intermediate Similarity	NPD6143	Clinical (unspecified phase)
0.7375	Intermediate Similarity	NPD2796	Approved
0.7372	Intermediate Similarity	NPD6859	Clinical (unspecified phase)
0.7356	Intermediate Similarity	NPD7184	Clinical (unspecified phase)
0.7354	Intermediate Similarity	NPD7497	Discontinued
0.7353	Intermediate Similarity	NPD5402	Approved
0.7349	Intermediate Similarity	NPD5403	Approved
0.7345	Intermediate Similarity	NPD7074	Phase 3
0.7333	Intermediate Similarity	NPD5401	Approved
0.7333	Intermediate Similarity	NPD2532	Approved
0.7333	Intermediate Similarity	NPD2534	Approved
0.7333	Intermediate Similarity	NPD4378	Clinical (unspecified phase)
0.7333	Intermediate Similarity	NPD2533	Approved
0.733	Intermediate Similarity	NPD7228	Approved
0.733	Intermediate Similarity	NPD7799	Discontinued
0.7329	Intermediate Similarity	NPD5763	Approved
0.7329	Intermediate Similarity	NPD5762	Approved
0.7329	Intermediate Similarity	NPD2346	Discontinued
0.7325	Intermediate Similarity	NPD8032	Phase 2
0.7312	Intermediate Similarity	NPD2799	Discontinued
0.7312	Intermediate Similarity	NPD3748	Approved
0.7312	Intermediate Similarity	NPD7033	Discontinued
0.731	Intermediate Similarity	NPD7768	Phase 2
0.7308	Intermediate Similarity	NPD7095	Approved
0.7303	Intermediate Similarity	NPD1608	Approved
0.7301	Intermediate Similarity	NPD4110	Phase 3
0.7301	Intermediate Similarity	NPD4109	Clinical (unspecified phase)
0.7301	Intermediate Similarity	NPD7003	Approved
0.7301	Intermediate Similarity	NPD8166	Discontinued
0.7299	Intermediate Similarity	NPD7229	Phase 3
0.7294	Intermediate Similarity	NPD8455	Phase 2
0.7294	Intermediate Similarity	NPD2801	Approved
0.7288	Intermediate Similarity	NPD7054	Approved
0.7288	Intermediate Similarity	NPD7804	Clinical (unspecified phase)
0.7284	Intermediate Similarity	NPD1549	Phase 2
0.7278	Intermediate Similarity	NPD4140	Approved
0.7267	Intermediate Similarity	NPD1551	Phase 2
0.7263	Intermediate Similarity	NPD7685	Pre-registration
0.7261	Intermediate Similarity	NPD3764	Approved
0.7261	Intermediate Similarity	NPD6798	Discontinued
0.7256	Intermediate Similarity	NPD6190	Approved
0.7253	Intermediate Similarity	NPD8150	Discontinued
0.7247	Intermediate Similarity	NPD7472	Approved
0.7241	Intermediate Similarity	NPD6959	Discontinued
0.7241	Intermediate Similarity	NPD1247	Approved
0.7239	Intermediate Similarity	NPD1243	Approved
0.7238	Intermediate Similarity	NPD8407	Phase 2
0.7232	Intermediate Similarity	NPD3751	Discontinued
0.7229	Intermediate Similarity	NPD7410	Clinical (unspecified phase)
0.7222	Intermediate Similarity	NPD6002	Phase 3
0.7222	Intermediate Similarity	NPD6004	Phase 3
0.7222	Intermediate Similarity	NPD6006	Clinical (unspecified phase)
0.7222	Intermediate Similarity	NPD6005	Phase 3
0.7222	Intermediate Similarity	NPD6003	Clinical (unspecified phase)
0.7222	Intermediate Similarity	NPD1552	Clinical (unspecified phase)
0.7222	Intermediate Similarity	NPD1550	Clinical (unspecified phase)
0.7222	Intermediate Similarity	NPD1471	Phase 3
0.7216	Intermediate Similarity	NPD7852	Clinical (unspecified phase)
0.7215	Intermediate Similarity	NPD6233	Phase 2
0.72	Intermediate Similarity	NPD3787	Discontinued
0.7197	Intermediate Similarity	NPD5952	Clinical (unspecified phase)
0.7193	Intermediate Similarity	NPD1465	Phase 2
0.7186	Intermediate Similarity	NPD7314	Clinical (unspecified phase)
0.7178	Intermediate Similarity	NPD970	Clinical (unspecified phase)
0.7174	Intermediate Similarity	NPD8397	Clinical (unspecified phase)
0.7169	Intermediate Similarity	NPD1511	Approved
0.7167	Intermediate Similarity	NPD7251	Discontinued
0.7167	Intermediate Similarity	NPD8368	Discontinued
0.7167	Intermediate Similarity	NPD7240	Approved
0.7152	Intermediate Similarity	NPD3268	Approved
0.7152	Intermediate Similarity	NPD2313	Discontinued
0.7143	Intermediate Similarity	NPD7097	Phase 1
0.7135	Intermediate Similarity	NPD7893	Clinical (unspecified phase)
0.7134	Intermediate Similarity	NPD2800	Approved
0.7127	Intermediate Similarity	NPD7808	Phase 3
0.7127	Intermediate Similarity	NPD4338	Clinical (unspecified phase)
0.7125	Intermediate Similarity	NPD5735	Approved
0.7117	Intermediate Similarity	NPD2344	Approved
0.7111	Intermediate Similarity	NPD6797	Phase 2
0.7105	Intermediate Similarity	NPD17	Approved
0.7099	Intermediate Similarity	NPD4308	Phase 3
0.7099	Intermediate Similarity	NPD1510	Phase 2
0.7083	Intermediate Similarity	NPD1512	Approved
0.7083	Intermediate Similarity	NPD7435	Discontinued
0.7081	Intermediate Similarity	NPD6653	Approved
0.7078	Intermediate Similarity	NPD3972	Approved
0.7062	Intermediate Similarity	NPD3926	Phase 2
0.7055	Intermediate Similarity	NPD2935	Discontinued
0.7052	Intermediate Similarity	NPD5616	Clinical (unspecified phase)
0.7051	Intermediate Similarity	NPD2797	Approved
0.7048	Intermediate Similarity	NPD3887	Approved
0.7048	Intermediate Similarity	NPD2354	Approved
0.7039	Intermediate Similarity	NPD7177	Discontinued
0.7031	Intermediate Similarity	NPD3057	Approved
0.7025	Intermediate Similarity	NPD6832	Phase 2
0.7022	Intermediate Similarity	NPD4575	Clinical (unspecified phase)
0.7019	Intermediate Similarity	NPD230	Phase 1
0.7018	Intermediate Similarity	NPD7028	Phase 2
0.7016	Intermediate Similarity	NPD4107	Approved
0.7011	Intermediate Similarity	NPD7058	Phase 2
0.7011	Intermediate Similarity	NPD7057	Phase 3
0.7006	Intermediate Similarity	NPD6007	Clinical (unspecified phase)
0.7	Intermediate Similarity	NPD8470	Clinical (unspecified phase)
0.6993	Remote Similarity	NPD1778	Approved
0.6989	Remote Similarity	NPD8361	Approved
0.6989	Remote Similarity	NPD8360	Approved
0.6989	Remote Similarity	NPD8435	Approved
0.6977	Remote Similarity	NPD6677	Suspended
0.6975	Remote Similarity	NPD1607	Approved
0.6973	Remote Similarity	NPD8424	Clinical (unspecified phase)
0.697	Remote Similarity	NPD2424	Discontinued
0.6957	Remote Similarity	NPD4307	Phase 2
0.6957	Remote Similarity	NPD1240	Approved
0.6957	Remote Similarity	NPD4060	Phase 1
0.6951	Remote Similarity	NPD2438	Suspended
0.6946	Remote Similarity	NPD2309	Approved
0.6943	Remote Similarity	NPD3266	Approved
0.6943	Remote Similarity	NPD3267	Approved
0.6943	Remote Similarity	NPD3533	Approved
0.6943	Remote Similarity	NPD2972	Approved
0.6937	Remote Similarity	NPD6410	Clinical (unspecified phase)
0.6937	Remote Similarity	NPD1699	Clinical (unspecified phase)
0.6928	Remote Similarity	NPD6674	Discontinued
0.6927	Remote Similarity	NPD6779	Approved
0.6927	Remote Similarity	NPD6777	Approved
0.6927	Remote Similarity	NPD6782	Approved
0.6927	Remote Similarity	NPD6776	Approved
0.6927	Remote Similarity	NPD6781	Approved
0.6927	Remote Similarity	NPD6778	Approved
0.6927	Remote Similarity	NPD6780	Approved
0.6914	Remote Similarity	NPD447	Suspended
0.6914	Remote Similarity	NPD5124	Phase 1
0.6914	Remote Similarity	NPD5123	Clinical (unspecified phase)
0.6899	Remote Similarity	NPD2798	Approved

Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity

B: biological targets similarity

C: networks similarity

D: cell-based bioactivity similarity

E: similarity based on clinical data